As of 2026-03-11, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 48.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.34 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 14153.4%.
The range of the Relative Valuation is 28.22 - 75.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 22.6x | 19.9x |
| Forward P/E multiples | 15.8x - 22.4x | 19.2x |
| Fair Price | 28.22 - 75.42 | 48.62 |
| Upside | 8173.3% - 22010.3% | 14153.4% |
| Date | P/E |
| 2026-03-09 | 0.21 |
| 2026-03-02 | 0.09 |
| 2026-02-27 | 0.09 |
| 2026-02-26 | 0.12 |
| 2026-02-19 | 0.12 |
| 2026-02-13 | 0.15 |
| 2026-02-12 | 0.15 |
| 2026-02-09 | 0.15 |
| 2026-02-06 | 0.15 |
| 2026-02-05 | 0.15 |
| 2026-02-03 | 0.15 |
| 2026-01-30 | 0.15 |
| 2026-01-27 | 0.21 |
| 2026-01-21 | 0.43 |
| 2026-01-16 | 0.31 |
| 2026-01-14 | 0.52 |
| 2026-01-13 | 0.21 |
| 2026-01-12 | 0.21 |
| 2026-01-08 | 0.23 |
| 2026-01-07 | 0.21 |
| 2026-01-05 | 0.21 |
| 2026-01-02 | 0.21 |
| 2025-12-31 | 0.43 |
| 2025-12-30 | 0.21 |
| 2025-12-29 | 0.20 |
| 2025-12-26 | 0.20 |
| 2025-12-24 | 0.28 |
| 2025-12-23 | 0.28 |
| 2025-12-22 | 0.20 |
| 2025-12-19 | 0.18 |
| 2025-12-18 | 0.14 |
| 2025-12-17 | 0.09 |
| 2025-12-16 | 0.06 |
| 2025-12-15 | 0.37 |
| 2025-12-12 | 0.34 |
| 2025-12-11 | 0.31 |